Origin Therapeutics
C$0.025000
7
+C$0.00+0%Monday 21:30
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
5.03M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-14,748.28%Profit Margin
Unprofitable29,000Revenue
-4.28MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Origin Therapeutics Holdings Inc. functions as an investment firm, predominantly focusing its efforts on the burgeoning psychedelic industry within Canada. Its strategic intent is to finance various stages of development, including scientific research, product conceptualization, manufacturing, quality control, market penetration, and sales of psychedelic substances, alongside any related endeavors. Incorporated in 2020, the company, originally known as 1278700 B.C. Ltd., maintains its main office in Vancouver, Canada.
Show More
CEO
Mr. Wah Chin Lee B.B.A., CPA, CGA
Country
Canada
ISIN
CA68622H1073
WKN
000A42BKK
Listings
0 Comments
Share your thoughts
FAQs
What is Origin Therapeutics stock price today?▼
The current price of ORIG.CN is C$0.03 CAD — it has increased by +0% in the past 24 hours. Watch Origin Therapeutics stock price performance more closely on the chart.
What is Origin Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Canadian Securities Exchange exchange Origin Therapeutics stocks are traded under the ticker ORIG.CN.
What is Origin Therapeutics market cap?▼
Today Origin Therapeutics has the market capitalization of 5.03M
What is Origin Therapeutics revenue for the last year?▼
Origin Therapeutics revenue for the last year amounts to 29,000 CAD.
What is Origin Therapeutics net income for the last year?▼
ORIG.CN net income for the last year is -4.28M CAD.
In which sector is Origin Therapeutics located?▼
Origin Therapeutics operates in the Health & Wellness sector.
When did Origin Therapeutics complete a stock split?▼
The last stock split for Origin Therapeutics was on October 3, 2023 with a ratio of 1:4.
Where is Origin Therapeutics headquartered?▼
Origin Therapeutics is headquartered in Vancouver, Canada.